Country: Malta
Language: English
Source: Medicines Authority
VENLAFAXINE
Actavis Group PTC ehf Revkjavikurvegi 76-78, 220 Hafnarfjordur, Iceland
N06AX16
VENLAFAXINE 75 mg
PROLONGED-RELEASE HARD CAPSULE
VENLAFAXINE 75 mg
POM
PSYCHOANALEPTICS
Withdrawn
2009-07-28
dimensions: pharmacode: date sent: TECHNICAL APPROVAL min pt size: awstudio@actavis.co.uk print proof no: origination date: originated by: revision date: supplier: technically app . date* : * Please note the technical approval is provided by the supplier and is valid on the date indicated. Any technical changes made by the supplier after approval are not the responsibility of the Artwork Studio. Non Printing Colours colours/plates revised by: approved for print/date 1. 2. 3. 4. 5. 6. black 1 8pt 190x600 01.07.2016 01.07.2016 KM Dupnitsa Item number: AAAJ1388 Venlafaxine SR 37.5mg, 75mg, 150mg, PIL, Malta READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Efevelon XL is and what it is used for 2. What you need to know before you take Efevelon XL 3. How to take Efevelon XL 4. Possible side effects 5. How to store Efevelon XL 6. Contents of the pack and other information 1. WHAT EFEVELON XL IS AND WHAT IT IS USED FOR Efevelon XL is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. It is thought that people who are depressed and/or anxious have lower levels of serotonin and noradrenaline in the brain. It is not fully understood how antidepressants work, but they may help by increasing the levels of serotonin and noradrenaline in the brain. Efevelon XL is a treatment for adults with depression. Efevelon XL is also a treatment f Read the complete document
SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Efevelon XL 37.5 mg prolonged-release capsules, hard Efevelon XL 75 mg prolonged-release capsules, hard Efevelon XL 150 mg prolonged-release capsules, hard 2. QUALITATIVE AND QUANTITATIVE COMPOSITION [For 37.5 mg strength:] One capsule contains venlafaxine hydrochloride, equivalent to 37,5 mg of venlafaxine. Excipients with known effect: sucrose max. 46.35 mg ponceau 4R red (E124) 0.0267 mg [For 75 mg strength:] One capsule contains venlafaxine hydrochloride, equivalent to 75 mg of venlafaxine. Excipients with known effect: sucrose max. 92.69 mg sunset yellow FCF (E110) 0.0006 mg [For 150 mg strength:] One capsule contains venlafaxine hydrochloride, equivalent to 150 mg of venlafaxine. Excipients with known effect: sucrose max. 185.38 mg sunset yellow FCF (E110) 0.0183mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Prolonged-release capsule, hard. Efevelon XL 37.5 mg prolonged-release capsules, hard: White to off-white granules in a capsule size “3” with an orange cap and transparent body. Efevelon XL 75 mg prolonged-release capsules, hard: White to off-white granules in a capsule size “1” with a yellow cap and transparent body. Efevelon XL 150 mg prolonged-release capsules, hard: White to off-white granules in a capsule size “0” with a buff cap and transparent body. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of major depressive episodes. For prevention of recurrence of major depressive episodes. Treatment of generalised anxiety disorder. Treatment of social anxiety disorder Treatment of panic disorders, with or without agoraphobia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology MAJOR DEPRESSIVE EPISODES The recommended starting dose for prolonged-release venlafaxine is 75 mg given once daily. Patients not responding to the initial 75 mg/day dose may benefit from dose increases up to a maximum dose of 375 mg/day. Dosage increases can be made at intervals of 2 w Read the complete document